Advertisement
Advertisement

Read Now: News and Research From IDWeek 2014

Medical News

Rethinking the Socioeconomics and Geography of Tuberculosis Among Foreign-Born Residents of New Jersey, 1994-1999

June 16, 2003


This article is part of The Body PRO's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

In the United States, TB among foreign-born persons has become a persistent concern because TB rates among the foreign-born have not declined in tandem with TB rates of the U.S.-born. According to the 1990 census, foreign-born persons accounted for only 8 percent of the population; yet 36 percent of TB cases occurred in this group in 1993-1998.

The epidemiological evidence connecting TB with socioeconomic deprivation is long-standing. Several studies have found neighborhood crowding to be strongly associated with TB rates; in one study, the association persisted even after control for AIDS prevalence.

The authors conceived the present study out of concern that the close association between poverty and TB may have been complicated by immigration patterns in the past decade, with potential consequences for TB treatment and control. If many TB patients are now concentrated in socioeconomically advantaged areas, the traditional health department model of care designed for populations in socioeconomically depressed areas may not be applicable.

The researchers analyzed TB case data collected by the New Jersey Department of Health and Senior Services for the years 1994-1999. During that time, 4,295 TB cases were identified in New Jersey: 2,290 were U.S.-born residents, one was Canadian-born, and 2,004 were other foreign-born residents. Of the 2,005 foreign-born cases, 991 (49.4 percent) were born in countries designated by the World Health Organization as high-burden TB countries. During this period, New Jersey averaged 30.1 cases per 100,000 foreign-born persons and 5.8 per 100,000 among U.S.-born persons.

Advertisement
The researchers found that foreign-born patients resided in more affluent, more educated, and less crowded areas than did U.S.-born patients. Foreign-born patients were more likely to have been employed during the two years prior to diagnosis. Private physicians treated the majority of South Asian-born patients.

Based on their research, the authors pointed out several implications for TB control:

  • If current trends continue, New Jersey can soon expect more than 300 foreign-born TB patients annually, with approximately one-third living in relatively affluent areas. However, any resource reallocation should be approached cautiously, given that nearly two-thirds of foreign-born patients still reside in areas with a lower socioeconomic profile.

  • If large numbers of foreign-born patients are treated by private physicians, those physicians will need to be better informed about correct TB treatment and latent TB infection.

  • If large numbers of foreign-born TB patients are employed during the two-year period prior to diagnosis, they are more likely to be working during their course of treatment and during their infectious period.

"Our analysis has revealed that the underserved population residing in urban areas long recognized to be at risk for TB lives alongside another population whose relative personal affluence and location defy time-honored epidemiological notions. There is substantial variability among foreign-born patients with respect to both personal and environmental socioeconomic indicators," the authors concluded. "As a result, future progress in TB control and elimination in the United States will require more complex solutions than have previously been recognized. TB among foreign-born residents and their children will continue to be a challenge to TB control measures, a challenge likely to persist as long as TB remains endemic in much of the developing world."

Back to other CDC news for June 16, 2003

Previous Updates

Adapted from:
American Journal of Public Health
06.03; Vol. 93; No. 6: P. 1007-1012; Amy L. Davidow, Ph.D.; Bonita T. Mangura, M.D.; Eileen C. Napolitano, B.A.; Lee B. Reichman, M.D., M.P.H.




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 

Advertisement